ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Macula-vitreous interface vitrectomy for pediatric epiretinal membrane: surgical principles, clinical outcomes and safety profile.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposesTo describe the surgical technique of Macula-Vitreous Interface Vitrectomy (MVIV), and report its clinical outcomes in pediatric patients with non-inflammatory epiretinal membrane (ERM).
methodsThis single-center retrospective case series included 42 pediatric patients (3 to 14 years) with unilateral non-inflammatory ERM who underwent MVIV between 2018 and 2023. MVIV involved selective removal of vitreous adjacent to the vitreomacular interface, primarily around the optic disc and macula within the vascular arcades, while preserving the central and peripheral vitreous. Outcomes included best-corrected visual acuity (BCVA), optical coherence tomography (OCT) parameters [central foveal thickness (CFT) or lesion thickness (LT)], intraocular pressure (IOP), and postoperative complications.
resultsMean age at surgery was 7.63 ± 2.97 years, with mean follow-up of 22.96 ± 11.43 months. BCVA improved from a median of 0.82 (IQR, 0.70-1.30) to 0.70 (IQR, 0.49-0.85), at 12 months (Hodges-Lehmann estimate, -0.20 logMAR; 95% CI, -0.29 to -0.10; P < .001).CFT/LT decreased significantly (both P < .001). ERM recurred in one eye (2.4%). No postoperative cataract, retinal detachment, proliferative vitreoretinopathy, or sustained IOP abnormalities were identified.
conclusionsMVIV was associated with favorable anatomical and visual outcomes and few short- and medium-term postoperative complications in this cohort. These findings support the feasibility of MVIV as a surgical option for selected pediatric patients with non-inflammatory ERM. Further comparative studies with longer follow-up are warranted to define its role relative to conventional vitrectomy techniques.
Indexed as
Identifiers
42711570What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.